The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
DKK 2016 | iwCLL 2017 | International Workshop on Chronic Lymphocytic Leukemia
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Michael Hallek, MD, from the University of Cologne, Cologne, Germany, discusses the upcoming International Workshop on Chronic Lymphocytic Leukemia (iwCLL) in New York, NY, during May 2017.
The themes of the iwCLL will highlight the latest advances in the management of chronic lymphocytic leukemia CLL, including the treatment of relapsed disease; optimization of treatment combinations; understanding of molecular changes in tumor cells; and clinically meaningful interactions within the tumor microenvironment.
http://www.iwcll2017.org/
